Literature DB >> 9726581

Medullomyoblastoma. A rare cerebellar tumour in children.

A K Mahapatra1, A K Sinha, M C Sharma.   

Abstract

Seven patients between the ages of 3 and 24 years were admitted to our hospital in the last 28 years who had a histological diagnosis of medullomyoblastoma. These patients presented with classic symptoms of a posterior fossa midline mass associated with evidence of raised ICP. A CT scan in each patient revealed a uniformly high-attenuating tumour in the posterior fossa with gross hydrocephalus. In all seven patients a ventriculoperitoneal shunt was placed prior to definitive surgery. Radical tumour excision was carried out in all cases 3-5 days after CSF diversion. The histological diagnosis was made on H&E-stained slides. In two cases each, the tumour tissue was subjected to electron microscopy and immunohistochemical studies. Six of the seven patients survived the operation. One patient died 21 days after surgery as a result of shunt block and shunt infection. All surviving patients received cranial and spinal radiation 2-4 weeks after surgery, and also chemotherapy. The cranial radiation dose ranged from 4500 to 5000 rad, while the spinal radiation dose was limited to 1500 rad. Patients were followed up carefully. Three patients died within 6 months, and the remaining three between 2.5 and 3 years after surgery. None of the patients in our study survived longer than 3 years. One patient had developed paraplegia. This study highlights the details of an uncommon entity and reports the largest collection of such cases in the literature.

Entities:  

Mesh:

Year:  1998        PMID: 9726581     DOI: 10.1007/s003810050232

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  5 in total

1.  A paediatric supratentorial primitive neuroectodermal tumour associated with malignant astrocytic transformation and a clonal origin of both components.

Authors:  Susanne A Kuhn; Uwe-Karsten Hanisch; Kristian Ebmeier; Christian Beetz; Michael Brodhun; Rupert Reichart; Christian Ewald; Thomas Deufel; Rolf Kalff
Journal:  Neurosurg Rev       Date:  2007-02-27       Impact factor: 3.042

2.  Medulloblastoma with myogenic differentiation: long-term survival in a patient treated with aggressive combination therapy and autologous stem cell transplantation.

Authors:  William Rattenberry; Colleen H McDonough; Peter C Burger; Kenneth J Cohen
Journal:  J Neurooncol       Date:  2011-06-19       Impact factor: 4.130

Review 3.  Recent advances in embryonal tumours of the central nervous system.

Authors:  Chitra Sarkar; Prabal Deb; Mehar Chand Sharma
Journal:  Childs Nerv Syst       Date:  2005-01-29       Impact factor: 1.475

4.  The role of immunohistochemistry in medullomyoblastoma--a case series highlighting divergent differentiation.

Authors:  Man Updesh S Sachdeva; Mahesha Vankalakunti; Aruna Rangan; Bishan D Radotra; Rajesh Chhabra; Rakesh K Vasishta
Journal:  Diagn Pathol       Date:  2008-04-25       Impact factor: 2.644

5.  Medullomyoblastoma: A rare case in an unusual location in an atypical age group.

Authors:  Sumit Bansal; Sachin A Borkar; Ashish Suri; Mehar C Sharma; Ashok K Mahapatra
Journal:  Asian J Neurosurg       Date:  2016 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.